ask="1.300"
ask_size="500"
average_daily_volume="98468"
bid="0.700"
bid_size="200"
book_value="0.694"
change="-0.014"
change_from_200_day_moving_average="-0.272"
change_from_50_day_moving_average="-0.013"
change_from_52_week_high="-6.754"
change_From_52_week_low="0.276"
change_in_percent="-1.157%"
close="1.196"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.156"
ebitda="-17.60M"
eps_estimate_current_year="-1.090"
eps_estimate_next_quarter="-0.290"
eps_estimate_next_year="-0.820"
ex_dividend_date="N/A"
float_shares="6119000"
high="1.370"
high_52_weeks="7.950"
last_trade_date="2/15/2017"
last_trade_price="1.196"
last_trade_size="1600"
last_trade_time="3:59pm"
low="1.180"
low_52_weeks="0.920"
market_capitalization="19.60M"
moving_average_200_day="1.468"
moving_average_50_day="1.209"
name="Bioblast Pharma Ltd."
notes="N/A"
one_year_target_price="9.000"
open="1.180"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-18.527%"
percent_change_from_50_day_moving_average="-1.080%"
percent_change_from_52_week_high="-84.956%"
percent_change_from_52_week_low="+29.972%"
previous_close="1.210"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.744"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16391000"
short_ratio="1.590"
stock_exchange="NGM"
symbol="ORPN"
volume="236483"
weeks_range_52="0.920 - 7.950"
